Impact of Inflammation on Midazolam Metabolism in Severe COVID‐19 Patients
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Pharmacology and Therapeutics"
DOI: 10.1002/cpt.2698
Abstract: Midazolam is a benzodiazepine frequently used for sedation in patients hospitalized in the intensive care unit (ICU) for coronavirus disease 2019 (COVID‐19). This drug is primarily metabolized by cytochrome P450 3A (CYP3A) isoenzymes. Several studies… read more here.
Keywords: cyp3a; inflammation; metabolism; inflammation midazolam ... See more keywords